πŸ‡ΊπŸ‡Έ FDA
Patent

US 7498442

Quinolinone-carboxamide compounds

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7498442 (Quinolinone-carboxamide compounds) held by Theravance, Inc. expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/12